Thiomersal-free influenza split vaccine 2002/2003
Showing 26 - 50 of >10,000
Influenza, Human Trial in Georgia, Turkey (aQIV, QIV)
Not yet recruiting
- Influenza, Human
- aQIV
- QIV
-
Batumi, Georgia
- +16 more
Oct 11, 2023
Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention Trial in Mechelen (ExPEC9V, Placebo, HD
Recruiting
- Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
- ExPEC9V
- +2 more
-
Mechelen, BelgiumAz Sint-Maarten
Nov 13, 2023
Vaccination; Infection Trial (Vaccine injection)
Not yet recruiting
- Vaccination; Infection
- Vaccine injection
- (no location specified)
Oct 12, 2023
Influenza Trial in Ansan-si, Incheon, Seoul (Quadrivalent influenza vaccine (QIV) (split virion, inactivated) Northern
Completed
- Influenza
- Quadrivalent influenza vaccine (QIV) (split virion, inactivated) Northern Hemisphere (NH) 2015-2016
- Trivalent influenza vaccine (TIV) (split virion, inactivated) NH 2015-2016 formulation
-
Ansan-si, Korea, Republic of
- +4 more
Mar 15, 2022
Influenza A, Pandemic Influenza Trial in Oslo (H7HLAII)
Recruiting
- Influenza A
- Pandemic Influenza
- H7HLAII
-
Oslo, NorwayOslo University Hospital
Sep 20, 2023
Influenza Trial in Novosibirsk (Flu-M Quadro [inactivated split influenza vaccine] with preservative, Flu-M Quadro [inactivated
Completed
- Influenza
- Flu-M Quadro [inactivated split influenza vaccine] with preservative
- +2 more
-
Novosibirsk, Russian FederationFederally Funded Healthcare Institution Primary Healthcare Unit
Dec 16, 2021
Seasonal Influenza Trial in United States (mRNA-1011.1, mRNA-1011.2, mRNA-1012.1)
Recruiting
- Seasonal Influenza
- mRNA-1011.1
- +5 more
-
Lakewood, California
- +21 more
Apr 12, 2023
Influenza, COVID-19, Influenza Immunogencity Trial in United States (Simultaneous Vaccination (Influenza Vaccine and mRNA COVID
Not yet recruiting
- Influenza
- +3 more
- Simultaneous Vaccination (Influenza Vaccine and mRNA COVID booster)
- +2 more
-
Phoenix, Arizona
- +7 more
Aug 30, 2023
Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in
Suspended
- Influenza Vaccine Effectiveness
-
Gainesville, Florida
- +11 more
Jan 13, 2023
Respiratory Syncytial Virus Trial in United States (Placebo, mRNA-1345, Fluzone HD)
Not yet recruiting
- Respiratory Syncytial Virus
- Placebo
- +2 more
-
Scottsdale, Arizona
- +32 more
Sep 23, 2023
COVID-19, Influenza, Vaccine Reaction Trial in Seoul, Incheon (Omicron-containing COVID-19 vaccine, influenza vaccine)
Recruiting
- COVID-19
- +3 more
- Omicron-containing COVID-19 vaccine
- influenza vaccine
-
Seoul, Guro-gu, Korea, Republic of
- +1 more
Oct 17, 2023
Influenza, Vaccine Trial in Durham, Cincinnati (cH8/1N1 LAIV, AS03-adjuvanted cH5/1N1 IIV, cH5/1N1 IIV)
Completed
- Influenza
- Vaccine
- cH8/1N1 LAIV
- +5 more
-
Durham, North Carolina
- +1 more
Feb 1, 2021
Influenza, Behavior and Behavior Mechanisms Trial in Hellerup (Behavioral Economic Principles)
Recruiting
- Influenza
- Behavior and Behavior Mechanisms
- Behavioral Economic Principles
-
Hellerup, Hovedstaden, DenmarkCenter for Translational Cardiology and Pragmatic Randomized Tri
Sep 8, 2023
Immune Response, Safety Trial in Incheon (bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine, quadrivalent influenza
Active, not recruiting
- Immune Response
- Safety
- bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine
- quadrivalent influenza vaccine
-
Incheon, Seo-gu, Korea, Republic ofInternational St. Mary's hospital
Jul 28, 2023
Uptake of Childhood Live Attenuated Influenza Vaccine and
Completed
- Influenza
-
London, United KingdomCPRD
Oct 4, 2023
Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine
Not yet recruiting
- Influenza, Human
- ARCT-2138
- +2 more
-
Brisbane, Queensland, AustraliaNucleus Network Brisbane Clinic
Nov 8, 2023
Influenza, Respiratory Tract Infections Trial (Portal-based Video Message, Portal-based Infographic Message)
Not yet recruiting
- Influenza
- Respiratory Tract Infections
- Portal-based Video Message
- Portal-based Infographic Message
- (no location specified)
Sep 25, 2023
Influenza, Human Trial in Worldwide (QIVc, Comparator)
Active, not recruiting
- Influenza, Human
- QIVc
- Comparator
-
Dobrich, Bulgaria
- +54 more
Jan 17, 2023
Influenza Trial in Lianyungang (Quadrivalent influenza vaccine)
Completed
- Influenza
- Quadrivalent influenza vaccine
-
Lianyungang, Jiangsu, ChinaDonghai County Center for Disease Control and Prevention
Aug 13, 2022
Seasonal Influenza Trial in Huai'an (Two doses of quadrivalent influenza vaccine, One dose of quadrivalent influenza vaccine)
Completed
- Seasonal Influenza
- Two doses of quadrivalent influenza vaccine
- One dose of quadrivalent influenza vaccine
-
Huai'an, Jiangsu, ChinaHuaiyin Center for Disease Control and Prevention
Aug 9, 2022
Healthy Trial (IL-YANG FLU Vaccine Prefilled Syringe INJ., Fluarix Tetra Pre-filled Syringe)
Not yet recruiting
- Healthy
- IL-YANG FLU Vaccine Prefilled Syringe INJ.
- Fluarix Tetra Pre-filled Syringe
- (no location specified)
Aug 23, 2021
Vaccine Reaction Trial in New Haven (MicronJet, Fluzone® Quadrivalent)
Not yet recruiting
- Vaccine Reaction
- MicronJet
- Fluzone® Quadrivalent
-
New Haven, ConnecticutChurch Street Research Unit
Sep 27, 2023
Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (Standard Dose Quadrivalent Inactivated
Not yet recruiting
- Immunization; Infection
- +2 more
- Standard Dose Quadrivalent Inactivated Influenza Vaccine
- High Dose Quadrivalent Inactivated Influenza Vaccine
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 11, 2023
Influenza Trial in Ghent (TETRALITE)
Active, not recruiting
- Influenza
- TETRALITE
-
Ghent, BelgiumCEVAC, University Hospital
Nov 16, 2022
Influenza, Behavior and Behavior Mechanisms Trial in Hellerup (Behavioral Economic Principles)
Recruiting
- Influenza
- Behavior and Behavior Mechanisms
- Behavioral Economic Principles
-
Hellerup, Hovedstaden, DenmarkCenter for Translational Cardiology and Pragmatic Randomized Tri
Sep 8, 2023